✦ LIBER ✦

Prevalence and Risk Factors for Clinically Significant Drug Interactions with Antiretroviral Therapy

✍ Scribed by Dr. Christopher D. Miller; Mr. Ramy El-Kholi; Dr. John J. Faragon; Dr. Thomas P. Lodise

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Recognition of Risk for Clinically Signi

✍ Evans‐Jones, John G.; Cottle, Lucy E.; Back, David J.; Gibbons, Sara; Beeching, 📂 Article 📅 2010 🏛 University of Chicago Press 🌐 English ⚖ 217 KB

Clinically Significant Drug Interactions

✍ Dr. Pannyun Yiu; Dr. Nancy N. Nguyen; Dr. Mark Holodniy 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 169 KB

Antiretroviral therapy hepatotoxicity: P

✍ Shicheng Gao; Xi-en Gui; Lipin Deng; Yongxi Zhang; Ke Liang; Rongrong Yang; Yaju 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 144 KB

Erectile dysfunction and statin therapy:

📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 346 KB

The prevalence and clinical significance

✍ Reyhan Diz-Kucukkaya; Veysel Sabri Hancer; Bahar Artim-Esen; Yuksel Pekcelen; Mu 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 192 KB

Risk factors for and clinical characteri

✍ M Osler; D Stead; K Rebe; G Meintjes; A Boulle 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 100 KB